Agios Pharmaceuticals Inc (STU:8AP)
€ 56 0 (0%) Market Cap: 3.20 Bil Enterprise Value: 2.30 Bil PE Ratio: 5.18 PB Ratio: 2.06 GF Score: 28/100

Agios Pharmaceuticals Inc at Citi Biotech Conference Transcript

Sep 05, 2019 / 04:00PM GMT
Release Date Price: €32.03 (+1.97%)
Mohit Bansal
Citigroup Inc, Research Division - VP and Analyst

Good afternoon, everyone. My name is Mohit Bansal. I'm one of the biotech analysts at Citi, and I have a pleasure to be joined by Jackie Fouse, CEO of Agios. And those who are on webcast, if you see -- if you hear any clicking here because people are eating here, so we are the only ones who don't get to eat. But thank you, Jackie, for joining us today. Thank you very much.

Jacqualyn A. Fouse
Agios Pharmaceuticals, Inc. - CEO & Director

Happy to be here.

Questions & Answers

Mohit Bansal
Citigroup Inc, Research Division - VP and Analyst

So Jackie, so exactly 1 year back, it was announced that you will take charge as a CEO. It has not been 1 year after you took charge, but could you help us understand what you have learned about the company so far. You were on the Board as well before, so you knew the company. But as in charge of execution, what have you learned about the company so far, the journey so far and the unique aspects of Agios,

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot